Paul Ginocchio - Augmedix Chief Officer

AUGXDelisted Stock  USD 2.35  0.00  0.00%   

Insider

Paul Ginocchio is Chief Officer of Augmedix
Age 54
Phone888 669 4885
Webhttps://www.augmedix.com

Augmedix Management Efficiency

The company has return on total asset (ROA) of (0.3061) % which means that it has lost $0.3061 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (3.2978) %, meaning that it created substantial loss on money invested by shareholders. Augmedix's management efficiency ratios could be used to measure how well Augmedix manages its routine affairs as well as how well it operates its assets and liabilities.
Augmedix currently holds 25.85 M in liabilities with Debt to Equity (D/E) ratio of 1.54, which is about average as compared to similar companies. Augmedix has a current ratio of 2.83, suggesting that it is liquid enough and is able to pay its financial obligations when due. Note, when we think about Augmedix's use of debt, we should always consider it together with its cash and equity.

Similar Executives

Showing other executives

INSIDER Age

Kenneth LaMontagneIn8bio Inc
N/A
Lawrence LambIn8bio Inc
69
Gerald ProehlDermata Therapeutics
65
Valerie MDElevation Oncology
46
John LorbieckiAclarion
61
David DornanElevation Oncology
46
Ryan BloomerElevation Oncology
N/A
Ryan BondAclarion
52
TaiWei HoIn8bio Inc
47
David HaleDermata Therapeutics
75
Brian SullivanElevation Oncology
N/A
Joseph FerraElevation Oncology
49
William HoIn8bio Inc
45
Kate RochlinIn8bio Inc
42
Trishna MDIn8bio Inc
45
RPh PharmDElevation Oncology
40
Augmedix, Inc. provides remote medical documentation solutions and live clinical support services in the United States. The company was founded in 2013 and is headquartered in San Francisco, California. Augmedix operates under Health Information Services classification in the United States and is traded on NASDAQ Exchange. It employs 706 people. Augmedix (AUGX) is traded on NASDAQ Exchange in USA and employs 1,430 people.

Management Performance

Augmedix Leadership Team

Elected by the shareholders, the Augmedix's board of directors comprises two types of representatives: Augmedix inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Augmedix. The board's role is to monitor Augmedix's management team and ensure that shareholders' interests are well served. Augmedix's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Augmedix's outside directors are responsible for providing unbiased perspectives on the board's policies.
Emmanuel Krakaris, CEO and President
Saurav Chatterjee, Chief Officer
Todd Holvick, Head Compliance
Jonathan Hawkins, Chief Officer
Tomer Levy, Senior Engineering
Lia Wallick, Head People
Davin MD, Chief Officer
Ian Shakil, Chief Founder
Paul Ginocchio, Chief Officer
Sandra Breber, Chief Officer

Augmedix Stock Performance Indicators

The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Augmedix a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in price.
You can also try the Pair Correlation module to compare performance and examine fundamental relationship between any two equity instruments.

Other Consideration for investing in Augmedix Stock

If you are still planning to invest in Augmedix check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Augmedix's history and understand the potential risks before investing.
Efficient Frontier
Plot and analyze your portfolio and positions against risk-return landscape of the market.
Latest Portfolios
Quick portfolio dashboard that showcases your latest portfolios
Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
Crypto Correlations
Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins
Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios
Balance Of Power
Check stock momentum by analyzing Balance Of Power indicator and other technical ratios
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope